Acute effect of the growth hormone antagonist pegvisomant injection alone and 
in combination with a somatostatin analogue on endogenous GH and pegvisomant 
levels

Roemmler, J.; Steffin, B.; Gutt, B.; Sievers, C.; Bidlingmaier, M.; Schopohl, J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Acute effect of the growth hormone antagonist pegvisomant injection alone and in combination with a somatostatin analogue on endogenous GH and pegvisomant levels

MPS-Authors

/persons/resource/persons80528

Sievers, C.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Roemmler, J., Steffin, B., Gutt, B., Sievers, C., Bidlingmaier, M., & Schopohl, J. (2007). Acute effect of the growth hormone antagonist pegvisomant injection alone and in combination with a somatostatin analogue on endogenous GH and pegvisomant levels. Experimental and Clinical Endocrinology & Diabetes, 115(8), 553-553.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-96A4-7

Abstract

There is no abstract available